OsI_24078 Antibody

What is OsI_24078 Antibody and what are its fundamental properties?

OsI_24078 Antibody (Product Code: CSB-PA979167XA01OFF) is a polyclonal antibody raised in rabbit against a recombinant Oryza sativa subsp. indica (Rice) OsI_24078 protein . The antibody targets the OsI_24078 protein (UniProt ID: A2YG32) with specificity for rice (Oryza sativa subsp. indica). It is purified using antigen affinity methods and is supplied in liquid form with a storage buffer containing 0.03% Proclin 300 as a preservative, 50% Glycerol, and 0.01M PBS at pH 7.4 .

The antibody has been tested and validated for applications including Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot (WB), making it suitable for protein detection and identification studies in rice research . As with all research-grade antibodies, it should be subject to proper validation in the specific experimental context where it will be used.

How should OsI_24078 Antibody be validated before experimental use?

Proper validation of OsI_24078 Antibody should follow the "five pillars" approach recommended by the International Working Group for Antibody Validation :

• Genetic strategy validation: Using knockout or knockdown rice plants/cells lacking OsI_24078 protein as negative controls to confirm antibody specificity.

• Orthogonal strategy validation: Comparing antibody-based detection results with antibody-independent methods (e.g., mass spectrometry or RNA-seq) to confirm target identification.

• Independent antibody validation: Using multiple antibodies targeting different epitopes of OsI_24078 to verify consistent results.

• Recombinant expression validation: Testing the antibody against samples with overexpressed OsI_24078 protein to confirm specific binding and signal increase.

• Immunocapture with mass spectrometry: Performing immunoprecipitation followed by mass spectrometry to confirm that captured proteins include OsI_24078.

Recent studies have demonstrated that many commercial antibodies lack adequate validation, underscoring the importance of these approaches for ensuring experimental reproducibility . For rice-specific proteins like OsI_24078, additional controls may be necessary due to potential cross-reactivity with related plant proteins.

What are the optimal storage and handling conditions for OsI_24078 Antibody?

To maintain the functional integrity of OsI_24078 Antibody, implement the following evidence-based storage protocol:

• Temperature conditions: Upon receipt, store at -20°C or -80°C to preserve antibody activity .

• Freeze-thaw considerations: Avoid repeated freeze-thaw cycles as these can significantly degrade antibody performance and specificity .

• Aliquoting strategy: Prepare single-use aliquots upon receipt to minimize freeze-thaw damage.

• Working solution stability: When diluted for experimental use, the antibody can typically be stored at 4°C for up to one week, though validation of stability at working dilution is recommended for your specific buffer conditions.

• Long-term storage: For experiments extending beyond 6 months, -80°C storage is preferable to -20°C to minimize degradation through proteolytic activity or aggregate formation.

The antibody's storage buffer (0.03% Proclin 300, 50% Glycerol, 0.01M PBS, pH 7.4) is specifically formulated to maintain stability during proper storage .

How can Western blotting protocols be optimized for OsI_24078 Antibody?

Western blotting with OsI_24078 Antibody requires specific optimization to ensure reliable and reproducible results:

Protocol Optimization Table for Western Blotting with OsI_24078 Antibody:

When optimizing, remember that the antibody has been specifically tested for Western blot applications to ensure identification of the antigen . A proper validation would include:

• Positive controls: Using recombinant OsI_24078 protein or rice samples known to express the protein.

• Negative controls: Using samples from species other than rice or samples where the protein has been depleted.

• Molecular weight confirmation: The detected band should match the predicted molecular weight of OsI_24078.

• Loading control: Include appropriate loading controls specific to plant samples, such as actin or tubulin.

Advanced researchers may consider orthogonal validation by correlating Western blot results with mass spectrometry or RNA expression data to confirm target specificity .

What strategies can minimize cross-reactivity when using OsI_24078 Antibody in complex rice samples?

Cross-reactivity is a significant concern with plant antibodies due to protein conservation across species. To minimize cross-reactivity issues with OsI_24078 Antibody:

• Pre-adsorption technique: Incubate the antibody with proteins from closely related plant species to remove antibodies that bind to conserved epitopes. This can be performed by:

  • Creating lysates from non-target plant tissues

  • Incubating diluted antibody with these lysates (5-10 mg/ml) for 2 hours at room temperature

  • Removing bound antibodies by centrifugation before using in the experiment

• Competition assays: Perform experiments with and without pre-incubation of the antibody with recombinant OsI_24078 protein. True target binding should be competitively inhibited .

• Stringent washing: Increase the stringency of washing steps (higher salt concentration, addition of 0.1% SDS or 0.5% Triton X-100) to remove weakly bound antibodies.

• Titration optimization: Determine the minimum antibody concentration that provides specific signal to minimize non-specific binding.

• Use of knockout/knockdown controls: Where available, samples lacking OsI_24078 expression provide the most definitive control for cross-reactivity assessment .

Studies have shown that competition experiments can help determine whether antibody reactivity represents true target binding or cross-reactivity to related proteins . For plant proteins specifically, competition with purified protein can reduce background signal by up to 60% in some cases.

How can immunoprecipitation protocols be adapted for OsI_24078 Antibody in plant tissue samples?

Immunoprecipitation (IP) with plant tissues presents unique challenges due to cell wall components, secondary metabolites, and high proteolytic activity. For optimal immunoprecipitation using OsI_24078 Antibody:

Step-by-Step Optimized Protocol:

• Tissue preparation:

  • Grind plant tissue in liquid nitrogen to a fine powder

  • Extract proteins in a plant-optimized IP buffer (100 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% NP-40, 1% Triton X-100, 1 mM EDTA, 3 mM DTT)

  • Add plant-specific protease inhibitor cocktail, PVPP (1%), and specific inhibitors of plant proteases

• Pre-clearing:

  • Incubate lysate with 50 μl Protein A/G beads per 1 ml lysate for 1 hour at 4°C

  • Remove beads by centrifugation (prevents non-specific binding)

• Antibody binding:

  • Incubate pre-cleared lysate with 2-5 μg OsI_24078 Antibody overnight at 4°C with rotation

  • For control samples, use pre-immune rabbit IgG at the same concentration

• Bead capture and washing:

  • Add 50 μl Protein A/G beads and incubate for 3 hours at 4°C

  • Wash 4-5 times with decreasing detergent concentrations

• Elution and analysis:

  • Elute proteins with 2X SDS sample buffer at 95°C for 5 minutes

  • Confirm successful IP by Western blot using a second antibody against OsI_24078 (if available) or the same antibody

• Validation by mass spectrometry:

  • Analyze IP samples by LC-MS/MS to confirm target capture

  • The presence of at least three peptide sequences from OsI_24078 would constitute good evidence of antibody selectivity

For advanced applications, recent research suggests that immunocapture followed by mass spectrometry provides the most definitive confirmation of antibody specificity, as recommended in the fifth pillar of antibody validation .

How can computational approaches predict epitope binding and improve experimental design for OsI_24078 Antibody?

Modern computational methods can significantly enhance experimental design for OsI_24078 Antibody research:

Advanced studies have demonstrated the effectiveness of machine learning approaches for antibody design, with one study evaluating 89,263 mutant antibodies using computational methods before experimental testing . Similar approaches can be adapted to assess OsI_24078 Antibody binding characteristics.

What constitutes comprehensive validation of OsI_24078 Antibody results for publication?

For publication-grade validation of results obtained with OsI_24078 Antibody, researchers should implement a multi-level validation strategy:

• Technical validation:

  • Demonstrate reproducibility across at least three independent experiments

  • Include all appropriate controls (positive, negative, isotype, secondary-only)

  • Show full blots with molecular weight markers and demonstrate specificity

  • Validate across multiple lots of the antibody if possible

• Biological validation:

  • Correlate antibody-based results with orthogonal methods (RNA-seq, mass spectrometry)

  • Demonstrate biological relevance through functional assays

  • Validate in multiple rice varieties or growth conditions

• Quantitative assessment:

  • Determine limit of detection and dynamic range

  • Assess coefficient of variation across replicates

  • Quantify signal-to-noise ratio in different experimental conditions

• Documentation requirements:

  • Report complete antibody information (catalog number, lot number, dilution, incubation conditions)

  • Describe all validation experiments in detail

  • Provide raw data and full-length blots in supplementary materials

Recent studies have highlighted that lack of adequate antibody characterization casts doubt on many published results . A survey of 614 commercial antibodies for 65 targets found that complete validation data was rarely presented in the literature . For plant antibodies specifically, the problem may be more pronounced due to fewer commercial validation resources.

How can mass spectrometry complement and validate OsI_24078 Antibody experiments?

Mass spectrometry (MS) provides a powerful orthogonal validation approach for antibody-based detection:

Integration of MS with Antibody-Based Methods:

• Immunoprecipitation-Mass Spectrometry (IP-MS):

  • Perform IP with OsI_24078 Antibody

  • Analyze captured proteins by LC-MS/MS

  • Identify OsI_24078 peptides and potential interacting partners

  • Quantify enrichment relative to control IPs

• Parallel Reaction Monitoring (PRM):

  • Develop PRM assays for specific OsI_24078 peptides

  • Compare quantification between antibody-based and MS-based methods

  • Use isotopically labeled peptide standards for absolute quantification

• Cross-linking MS (XL-MS):

  • Cross-link antibody to target protein

  • Analyze cross-linked peptides by MS

  • Map the actual epitope bound by the antibody

• Comparison workflow:

Mass spectrometry validation represents the fifth pillar of antibody validation recommendations . Recent research indicates that successful MS validation would identify at least three peptide sequences from OsI_24078 in immunoprecipitated samples, and these sequences should represent the top hits in the analysis .

How can contradictory results between different experimental approaches using OsI_24078 Antibody be resolved?

When faced with contradictory results across different experimental methods:

• Systematic troubleshooting approach:

  • Compare epitope accessibility across techniques (native vs. denatured)

  • Assess buffer compatibility and potential interfering compounds

  • Evaluate antibody lot-to-lot variability

  • Consider post-translational modifications that might affect recognition

• Decision tree for resolving contradictions:

  • If Western blot is positive but IP negative: Epitope may be masked in native conditions

  • If IP is positive but Western blot negative: Epitope may be destroyed by denaturation

  • If cell-based assays differ from biochemical assays: Consider subcellular localization or protein interactions

• Orthogonal validation strategy:

  • Employ antibody-independent methods (MS, RNA analysis)

  • Use multiple antibodies targeting different epitopes

  • Apply genetic approaches (overexpression, knockdown)

  • Use recombinant expression systems

• Quantitative discrepancy resolution:

  • Calculate limits of detection for each method

  • Determine dynamic range of each assay

  • Assess potential interference from sample matrix

Recent studies demonstrate that data from different antibody validation strategies often do not align perfectly . For Western blotting, 80% of antibodies recommended based on orthogonal strategies and 89% of antibodies recommended based on genetic strategies successfully detected their target proteins, highlighting the importance of using multiple validation approaches .

How might computational antibody design improve next-generation antibodies for plant proteins like OsI_24078?

Computational antibody design represents a promising frontier for improving plant protein antibodies:

• Machine learning approaches:

  • Deep learning models can predict optimal antibody sequences for specific epitopes

  • These approaches have successfully generated antibodies with improved binding characteristics

  • One study evaluated 89,263 mutant antibodies using computational methods to optimize binding

• Structure-based optimization:

  • Molecular dynamics simulations can predict antibody-antigen interactions

  • Free energy calculations can estimate binding affinities

  • These methods can optimize antibody design before synthesis

• High-throughput virtual screening:

  • Computational platforms can evaluate thousands of potential antibody variants

  • This approach dramatically reduces experimental testing requirements

  • In one case, researchers evaluated antibody designs in just 22 days using supercomputing resources

• Evolutionary sequence optimization:

  • Algorithms can evolve antibody sequences to maximize binding affinity

  • This approach mimics natural antibody maturation processes

  • The Patent and Literature Antibody Database (PLAbDab) provides growing resources for training these algorithms

These computational approaches could significantly improve antibody development for challenging targets like plant proteins, potentially addressing the current limitations in antibody specificity and reproducibility documented in recent literature .

What emerging technologies might complement or replace traditional antibody-based detection of OsI_24078?

Several emerging technologies offer alternatives or complements to traditional antibody applications:

• Aptamer technology:

  • DNA/RNA aptamers can be developed against specific protein targets

  • SELEX (Systematic Evolution of Ligands by Exponential Enrichment) can generate aptamers with high specificity

  • Advantages include chemical synthesis, thermal stability, and renewable supply

• Nanobody/single-domain antibody approaches:

  • Camelid-derived single-domain antibodies offer smaller size and enhanced stability

  • These can access epitopes unavailable to conventional antibodies

  • Expression in bacteria or yeast provides renewable, consistent supply

• Affimer/Affibody technology:

  • Non-antibody scaffold proteins engineered for specific binding

  • Smaller size enables better tissue penetration

  • Can be produced recombinantly with high consistency

• CRISPR-based detection:

  • CRISPR-Cas systems can be adapted for protein detection

  • These approaches offer potential for multiplexing and point-of-use applications

  • May overcome specificity limitations of antibodies

• Targeted mass spectrometry:

  • Parallel reaction monitoring (PRM) or selected reaction monitoring (SRM)

  • Direct protein quantification without antibodies

  • Increasing sensitivity makes this viable for low-abundance proteins

Recent reviews of antibody characterization challenges suggest that combining traditional antibody methods with these emerging technologies may provide the most robust approach for protein detection and characterization .